183 related articles for article (PubMed ID: 23067217)
41. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
[TBL] [Abstract][Full Text] [Related]
42. Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study.
Arafa M; Boniver J; Delvenne P
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):422-32. PubMed ID: 18542030
[TBL] [Abstract][Full Text] [Related]
43. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D
Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
[TBL] [Abstract][Full Text] [Related]
44. Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia.
Valasoulis G; Koliopoulos G; Founta C; Kyrgiou M; Tsoumpou I; Valari O; Martin-Hirsch P; Daponte A; Karakitsos P; Paraskevaidis E
Gynecol Oncol; 2011 Apr; 121(1):43-8. PubMed ID: 21216451
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
[TBL] [Abstract][Full Text] [Related]
46. Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6.
Wang W; Yue Z; Tian Z; Xie Y; Zhang J; She Y; Yang B; Ye Y; Yang Y
PLoS One; 2018; 13(2):e0193340. PubMed ID: 29470526
[TBL] [Abstract][Full Text] [Related]
47. TOP2A/MCM2, p16
Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
[TBL] [Abstract][Full Text] [Related]
48. Expression of HPV-induced DNA Damage Repair Factors Correlates With CIN Progression.
Spriggs CC; Blanco LZ; Maniar KP; Laimins LA
Int J Gynecol Pathol; 2019 Jan; 38(1):1-10. PubMed ID: 29995652
[TBL] [Abstract][Full Text] [Related]
49. Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues.
Xing Y; Wang C; Wu J
Medicine (Baltimore); 2017 Jun; 96(26):e7302. PubMed ID: 28658133
[TBL] [Abstract][Full Text] [Related]
50. Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia.
Lee YY; Song SY; Do IG; Kim TJ; Kim BG; Lee JW; Bae DS
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):180-4. PubMed ID: 22959143
[TBL] [Abstract][Full Text] [Related]
51. Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.
Lee H; Lee H; Cho YK
Diagn Pathol; 2017 Feb; 12(1):18. PubMed ID: 28212672
[TBL] [Abstract][Full Text] [Related]
52. E-cadherin and catenin expression in normal and neoplastic endocervical glandular epithelium.
Heatley MK
Histopathology; 2004 Aug; 45(2):200-2. PubMed ID: 15279644
[No Abstract] [Full Text] [Related]
53. Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
Am J Clin Pathol; 2009 Dec; 132(6):883-92. PubMed ID: 19926580
[TBL] [Abstract][Full Text] [Related]
54. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
Li Y; Liu J; Gong L; Sun X; Long W
Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
[TBL] [Abstract][Full Text] [Related]
55. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
56. Claudin-1 as a Biomarker of Cervical Cytology and Histology.
Benczik M; Galamb Á; Koiss R; Kovács A; Járay B; Székely T; Szekerczés T; Schaff Z; Sobel G; Jeney C
Pathol Oncol Res; 2016 Jan; 22(1):179-88. PubMed ID: 26463354
[TBL] [Abstract][Full Text] [Related]
57. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection.
Sasagawa T; Shimakage M; Nakamura M; Sakaike J; Ishikawa H; Inoue M
Hum Pathol; 2000 Mar; 31(3):318-26. PubMed ID: 10746674
[TBL] [Abstract][Full Text] [Related]
59. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
[TBL] [Abstract][Full Text] [Related]
60. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
